2619 Patterns and potential benefit of adjuvant chemotherapy for residual muscle invasive disease after neoadjuvant chemotherapy for muscle invasive urothelial cancer (MIUC). (September 2015) - Harshman, L.; Werner, L.; Wong, Y.N.; Yu, E.; Alva, A.; Crabb, S.; Powles, T.; Rosenberg, J.; Baniel, J.; Vaishampayan, U.; Berthold, D.; Ladoire, S.; et al.